Getinge AB Class B GETI B

Morningstar Rating
SEK 246.40 −0.80 (0.32%)
View Full Chart

Company Report

Getinge's Fundamentals Intact as Demand for High-Margin Products Remains Strong

Getinge is a Swedish medical technology firm specializing in operating room equipment, critical-care technologies, and sterilization solutions for hospitals and biopharmaceutical manufacturers. Over the past decade, the company has faced significant regulatory scrutiny, including a 2015 US consent decree, product liability settlements related to surgical mesh, multiple product recalls, and recent US Food and Drug Administration letters regarding its Cardiosave and Cardiohelp cardiovascular devices. These challenges have required increased investment in quality systems and product remediation, which has persistently pressured margins. With the recent FDA submission for Cardiosave, we hope Getinge can soon leave this chapter behind.

Price vs Fair Value

GETI B is trading within a range we consider fairly valued.
Price
SEK 247.20
Fair Value
$WX
Uncertainty
LOCK|Q%
1-Star Price
LOCK|j.#XD
5-Star Price
LOCK|y.r>
Economic Moat
LOCK|r<&
Capital Allocation
LOCK|g!#Yxm

Bulls Say, Bears Say

Bulls

Getinge benefits from stable long-term growth trends such as an aging population and increased healthcare spending, which are generally not affected by macroeconomic circumstances.

Bears

Getinge’s China business, which we estimate to be roughly 10% of total sales, is facing a slowdown, similar to that of its life science peers.

Trading Information

Previous Close Price
SEK 247.20
Day Range
SEK 245.90–248.80
52-Week Range
SEK 175.90–251.40
Bid/Ask
SEK 246.30 / SEK 246.50
Shares Outstanding
272.37M
Market Cap
SEK 67.11B
Volume/Avg
275,823 / 555,362

Key Statistics

Price/Earnings (Normalized)
22.11
Price/Sales
1.97
Dividend Yield (Trailing)
1.92%
Dividend Yield (Forward)
1.92%
Dividend Payment Schedule
Apr
Total Yield
1.92%

Company Profile

Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (35%), and life sciences (13%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales, Europe, Middle East, and Africa 35%, and Asia-Pacific the remaining 25%.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Mid Core
Total Number of Employees
11,758

Competitors

Valuation

Metric
GETI B
MDT
SYK
Price/Earnings (Normalized)
22.1115.2719.57
Price/Book Value
2.182.204.36
Price/Sales
1.972.964.08
Price/Cash Flow
12.7512.4018.68
Price/Earnings
GETI B
MDT
SYK

Financial Strength

Metric
GETI B
MDT
SYK
Quick Ratio
0.741.291.08
Current Ratio
1.312.072.16
Interest Coverage
7.2610.12—
Quick Ratio
GETI B
MDT
SYK

Profitability

Metric
GETI B
MDT
SYK
Return on Assets (Normalized)
5.85%8.31%11.44%
Return on Equity (Normalized)
11.17%15.59%23.97%
Return on Invested Capital (Normalized)
9.16%10.57%14.10%
Return on Assets
GETI B
MDT
SYK

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|BgZ<LJyLOCK|N>f@m$167B
Medtronic PLC
MDT
LOCK|@Q&?@!LOCK|!?>Wj$111B
Stryker Corp
SYK
LOCK|$<njx%jLOCK|S&y$105B
Boston Scientific Corp
BSX
LOCK|&BHpZG#LOCK|#!?L?$63B
Edwards Lifesciences Corp
EW
LOCK|d>$$Xv$LOCK|nJ&>@$49B
DexCom Inc
DXCM
LOCK|z?@PP?<>LOCK|TV^Q?$33B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|%MKrrzLOCK|TdW$29B
Koninklijke Philips NV ADR
PHG
LOCK|@<vLOCK|&$$23B
Steris PLC
STE
LOCK|r@SdDGHLOCK|&Ppm$20B
Zimmer Biomet Holdings Inc
ZBH
LOCK|<q#r@pbLOCK|BY$17B

Sponsor Center